2026-05-12T09:54:11+00:00 2025-06-30 440160260 Forvis Mazars LLP 255 South Orange Avenue Suite 600 Orlando FL 32801 990 2024-07-01 010554709 FLORIDA PROTON THERAPY INSTITUTE INC FLOR 9045881800 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 KRISTIN HEATH EXECUTIVE DIRECTOR 9045881241 2026-05-12 true true Peter Gubler P00190185 4077405400 2026-05-15 2024 2025-03-06 01:10:19Z KRISTIN HEATH 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 53067576 false X www.floridaproton.org X 2001 FL TO PROVIDE CANCER TREATMENT SERVICES, EDUCATIONAL PROGRAMS, AND TRAINING OPPORTUNITIES. 7 6 145 8 0 3242619 673858 45414564 49305415 1744706 2244738 866697 827154 51268586 53051165 0 8000 0 0 13477691 14403250 0 0 0 33108060 33393259 46585751 47804509 4682835 5246656 140234180 141325655 50275840 46145024 89958340 95180631 THE ORGANIZATION PROVIDES CANCER TREATMENT SERVICES, EDUCATIONAL PROGRAMS, AND TRAINING OPPORTUNITIES TO PROMOTE BASIC AND CLINICAL RESEARCH RELATED TO CANCER TREATMENTS AND TREATMENT PROGRAMS. false false 45695400 8000 50132569 THE PRIMARY ACTIVITY OF THE INSTITUTE IS TO PROVIDE PROTON AND CONVENTIONAL RADIATION THERAPY CANCER TREATMENT IN FACILITIES LOCATED IN JACKSONVILLE, FLORIDA. SINCE COMMENCING CLINICAL OPERATIONS IN AUGUST OF 2006, THE INSTITUTE HAS CONTINUED TO FOCUS ITS RESOURCES ON FULFILLING ITS TRIPARTITE MISSION OF CLINICAL SERVICE, RESEARCH AND EDUCATION. TO DATE, THE INSTITUTE HAS PROVIDED CANCER TREATMENT SERVICES TO OVER 18,415 PATIENTS. THE CLINICAL PROGRAMS FOCUS ON MULTIPLE DISEASE SITES INCLUDING, BUT NOT LIMITED TO: CANCERS OF THE BRAIN AND CENTRAL NERVOUS SYSTEM, PROSTATE, SOFT TISSUES, EYE, BREAST, LUNG AND PANCREAS. THE INSTITUTE CURRENTLY OPERATES THE WORLD'S LARGEST PEDIATRIC PROGRAM UTILIZING PROTON THERAPY. SUPPLEMENTAL RESOURCES DEDICATED TO THE PEDIATRIC POPULATION INCLUDE: A FULL-TIME PLAY THERAPIST, A PEDIATRIC SOCIAL WORKER AND ART THERAPY STAFF. ALSO, PEDIATRIC PATIENTS ARE PROVIDED VARIOUS EDUCATIONAL AND "FUN" EVENTS SUPPORTED BY: THE LOCAL ZOO, SCIENCE LADY, FIRE DEPARTMENT, ETC. A CORNERSTONE OF THE INSTITUTE'S MISSION INCLUDES CLINICAL RESEARCH. CURRENTLY, THE INSTITUTE HAS A TOTAL OF 149 CLINICAL TRIALS, OUTCOME STUDIES, AND REGISTRIES THAT HAVE BEEN COMPLETED OR ARE CURRENTLY OPEN FOR PATIENT ACCRUAL. THIS CLINICAL RESEARCH HAS LED TO OVER 450 PUBLICATIONS. APPROXIMATELY 97% OF THE INSTITUTE'S PATIENTS PARTICIPATE IN ONE OF THE CLINICAL TRIAL PROGRAMS OR OUTCOME STUDIES. LIKEWISE, THE INSTITUTE HAS DEVELOPED MULTIPLE EDUCATIONAL OPPORTUNITIES INCLUDING POST GRADUATE FELLOWSHIP TRAINING PROGRAMS IN PROTON RADIATION, PEDIATRICS AND IN MEDICAL PHYSICS. ALSO, THE INSTITUTE PROVIDES ONSITE TRAINING FOR SEVERAL RADIATION THERAPIST TRAINING PROGRAMS AND CHILD LIFE SPECIALIST SOCIAL WORKER PROGRAMS. AS A CANCER CENTER OF EXCELLENCE AND ACCREDITED RADIATION ONCOLOGY CENTER THROUGH THE AMERICAN COLLEGE OF RADIOLOGY (ACR), THE INSTITUTE CONTINUED TO PROVIDE OPTIMAL PATIENT CARE AND SERVICES. ALSO, THE INSTITUTE CONTINUES TO IMPROVE ITS ART-IN-MEDICINE PROGRAM, EDUCATIONAL ACTIVITIES, AND SURVIVORSHIP PROGRAM. THESE PROGRAMS ARE AIMED TO INCREASE THE HEALING ENVIRONMENT AND CULTURE CREATED AT THE INSTITUTE. PRIMARILY, THESE PROGRAMS ENHANCE WELLNESS, RELAXATION, PAIN MANAGEMENT, AND DECREASE ANXIETY AND STRESS IN PATIENTS AND CAREGIVERS UNDERGOING CANCER CARE AT THE INSTITUTE. THE PROGRAM HAS BEEN SO SUCCESSFUL THAT 98% OF PATIENTS WOULD DEFINITELY RECOMMEND THE INSTITUTE'S TREATMENT AND SERVICES. THE INSTITUTE IS RECOGNIZED AS THE WORLD LEADER IN PEDIATRIC PROTON RADIATION THERAPY AND CONTINUALLY PROVIDES TREATMENT TO PATIENTS FROM MANY COUNTRIES AROUND THE WORLD AS WELL AS MANY STATES WITHIN THE USA. THE ADULT PROGRAMS ARE EQUALLY RECOGNIZED FOR THE TREATMENT OPTIONS AND CONTINUED CANCER RESEARCH. CURRENTLY, THE INSTITUTE IS COLLECTING DATA, OR HAS COLLECTED DATA, ON RESEARCH STUDIES, EITHER FOR ITS OWN MISSION OR PARTICIPATING WITH OTHER NOTED MEDICAL INSTITUTIONS, SUCH AS ST. JUDE'S CHILDREN'S HOSPITAL, MASSACHUSETTS GENERAL HOSPITAL, ETC. IN FISCAL YEAR 2025 (JULY 1, 2024 THRU JUNE 30, 2025), THE INSTITUTE'S PROFESSIONAL STAFF PUBLISHED 35 STUDIES IN MAJOR MEDICAL PUBLICATIONS. 45695400 true true false false false false false false false true true false false true false true true false false false false false false false false false false true false true true false false false false false false false false false false false false false false false false false false false false true 32 0 true 145 true false false false false false false false false false false false false X 7 6 false false false false false true false true true false false false true true true true true true true false false false X VIVEK BADISA 9045881433 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 JENNIFER HUNT MD CHAIRMAN 0.3 X X 0 0 0 NANCY P MENDENHALL TRUSTEE/MEDICAL DIRECTOR 40.0 X X 647548 0 25987 ALAN MORRISON FORMER TRUSTEE (END. 11/24) 0.3 X 0 0 0 GAE WALTERS PHD TRUSTEE 0.3 X 0 0 0 GARY DILTS TRUSTEE 0.3 X 0 0 0 JONATHAN LICHT TRUSTEE 0.3 X 0 0 0 PATRICK GREEN TRUSTEE 0.3 X 0 0 0 PAUL OKUNIEFF FORMER TRUSTEE (END. 3/25) 0.3 X 0 0 0 TERRANCE FREEMAN TRUSTEE (Beg. 3/25) 0.3 X 0 0 0 KRISTIN A HEATH EXECUTIVE DIRECTOR 40.0 X 363842 0 46860 VIVEK BADISA CHIEF FINANCIAL OFFICER (BEG. 05/25)/TREASURER (NON-VOTING) 40.0 X 38001 0 0 BRADLEE ROBBERT DIRECTOR OF OPERATIONS/SECRETARY (NON-VOTING) 40.0 X 158705 0 5047 KEVIN KIRBY DIRECTOR OF CLINICAL DOSIMETRY 40.0 X 214522 0 6757 TREVOR FLEMING DIRECTOR OF TECHNICAL SERVICES 40.0 X 203813 0 6337 EMMA V VIVIERS TREATMENT PLANNING PHYSICIST 40.0 X 184407 0 5760 JOHN YOUNG TECHNICAL SERVICES MANAGER 40.0 X 139854 0 4423 NATALIYA GETMAN LEAD CERTIFIED MEDICAL DOSIMETRIST 40.0 X 157048 0 4869 ST JOHN ERNEST TECHNICAL SERVICES MANAGER 40.0 X 147012 0 4543 WILLIAM J GLIDDEN LEAD CERTIFIED MEDICAL DOSIMETRIST 40.0 X 163208 0 4991 WALTER MOORE CHIEF FINANCIAL OFFICER (END. 05/25) 40.0 X 143666 0 4392 2561626 0 119966 34 true true true UF DEPARTMENT OF RADIATION ONCOLOGY PO BOX 100385 GAINESVILLE FL 32610 STAFFING PROVIDER 9563230 IBA PROTON THERAPY INC 151 HEARTLAND BLVD EDGEWOOD NY 11717 EQUIPMENT MAINTENANCE 6637463 PHILIPS HEALTHCARE PO BOX 100355 ATLANTA GA 30384 EQUIPMENT MAINTENANCE 2556911 CHARLES PERRY PARTNERS INC 8200 NW 15th PLACE GAINESVILLE FL 32606 MRI CONSTRUCTION 1473456 RC BILLING PO BOX 659831-MSC 224 SAN ANTONIO TX 78265 BILLING SERVICES 1080220 28 673858 673858 NET PATIENT CARE REVENUE 621500 48257464 48257464 SHARED SERVICE REVENUE 621500 1047951 1047951 0 0 0 0 49305415 1839557 1839557 0 0 421592 0 0 16411 421592 -16411 405181 405181 OPERATION & MAINTENANCE REIMBURSE 621500 828270 828270 OTHER INCOME/LOSS 621500 -1116 -1116 0 0 0 0 827154 53051165 50132569 0 2244738 X 8000 8000 2005496 1477958 527538 9768318 9768318 156153 149156 6997 1662525 1588034 74491 810758 774431 36327 215121 215121 51832 51832 11617156 11014579 602577 0 1028840 925956 102884 338110 118051 220059 558710 542847 15863 10776624 10668858 107766 81314 81314 20654 20654 2132372 2111048 21324 4503403 4501653 1750 668268 661585 6683 SUPPLIES 1331551 1308922 22629 PATIENT PROGRAMS 42336 42336 RADIATION SAFETY 20039 6085 13954 TRAINING 6929 6929 0 0 0 0 47804509 45695400 2109109 0 6280226 1598010 15707859 21730685 5811189 6742432 0 0 0 0 1392356 1434545 119217869 64652737 55741910 54565132 27181434 28639449 0 0 28119206 26615402 140234180 141325655 4525856 3778068 45749984 42366956 0 0 0 0 50275840 46145024 X 86323046 91544537 3635294 3636094 89958340 95180631 140234180 141325655 X 5246656 300681 -325046 X false true true false X 3093472 2103823 1862803 3242619 673858 10976575 36585578 41702517 42323261 45414564 49305415 215331335 20000 20000 0 0 39699050 43806340 44186064 48657183 49979273 226327910 0 0 0 0 0 0 0 0 566111 1988247 0 2554358 0 0 566111 1988247 0 2554358 223773552 425518 210476 777404 1651395 1839557 4904350 0 425518 210476 777404 1651395 1839557 4904350 0 902253 851777 883561 866697 827154 4331442 41026821 44868593 45847029 51175275 52645984 235563702 0.94995 0.953 0.02 0.0163 X Schedule A, Part III, Line 12 Other Income DESCRIPTION - O&M UNIVERSITY OF FLORIDA, COLUMN A - 828270.0, COLUMN B - 828270.0, COLUMN C - 828269.0, COLUMN D - 828270.0, COLUMN E - 828270.0, COLUMN F - 4141349.0; DESCRIPTION - OTHER INCOME/LOSS, COLUMN A - 73983.0, COLUMN B - 23507.0, COLUMN C - 55292.0, COLUMN D - 38427.0, COLUMN E - -1116.0, COLUMN F - 190093.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3521142 800 3521942 1020242 2500900 3521142 1006957 13285 1020242 1001757 5200 1006957 800082 201675 1001757 0.0 1.0 0.0 true false 3119257 1489102 1630155 116096512 63163635 52932877 2100 2100 54565132 DEPOSITS 111657 INTEREST IN LEASEHOLD 19872878 OTHER RECEIVABLES 732803 FAIR VALUE OF INTEREST RATE SWAP AGREEMENTS 416780 BENEFICIAL INTEREST IN ASSETS HELD BY OTHERS 5481284 26615402 0 X 52943341 300681 -325046 -24365 52967706 83459 0 83459 53051165 47721050 0 0 47721050 83459 0 83459 47804509 Schedule D, Part V, Line 3a(i) THE FILING ORGANIZATION'S ENDOWMENT FUNDS ARE HELD AND ADMINISTERED BY THE UNIVERSITY OF FLORIDA FOUNDATION ("THE FOUNDATION"). THE FOUNDATION IS AN UNRELATED NOT-FOR-PROFIT ENTITY WHOSE PRIMARY PURPOSE IS TO RAISE FUNDS TO SUPPORT THE UNIVERSITY AND OTHER CHARITABLE ORGANIZATIONS, INCLUDING THE INSTITUTE. THE INSTITUTE HAS RECOGNIZED ITS INTEREST IN CONTRIBUTIONS RECEIVED AND HELD BY THE FOUNDATION THAT HAVE BEEN DESIGNATED BY THE DONOR FOR THE BENEFIT OF THE INSTITUTE. Schedule D, Part V, Line 4 Intended uses of endowment funds ENDOWMENT FUNDS ARE ESTABLISHED AS A MEANS TO PROVIDE FUTURE CASH FLOWS FOR OPERATIONS AND OTHER PURPOSES DESIGNATED BY THE INSTITUTE'S DONORS. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote THE INSTITUTE IS RECOGNIZED AS AN ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER 501(A) AS ENTITIES DESCRIBED IN SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE, EXCEPT FOR TAXES ON INCOME FROM ACTIVITIES UNRELATED TO ITS EXEMPT PURPOSES. THE INSTITUTE DOES NOT HAVE ANY MATERIAL, UNRECOGNIZED TAX POSITIONS THAT SHOULD BE RECOGNIZED IN THE FINANCIAL STATEMENTS FOR THE YEARS ENDED JUNE 30, 2025 OR 2024. Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 CHANGE IN FAIR VALUE OF INTEREST RATE SWAP - -325046 Ronald McDonald House Charities of Jacksonville Inc 824 CHILDRENS WAY JACKSONVILLE FL 32207 592625008 501(c)(3) 7500 GENERAL SUPPORT 1 0 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds TO ORGANIZATION PROVIDES GRANTS TO ORGANIZATIONS IN SUPPORT OF ITS MISSION AND PROGRAM SERVICES. false false false false false false false false false NANCY P MENDENHALL TRUSTEE/MEDICAL DIRECTOR 647548 0 0 0 0 0 25987 0 0 0 673535 0 0 0 WALTER MOORE CHIEF FINANCIAL OFFICER (END. 05/25) 143666 0 0 0 0 0 4392 0 0 0 148058 0 0 0 KRISTIN A HEATH EXECUTIVE DIRECTOR 363842 0 0 0 0 0 46860 0 0 0 410702 0 0 0 KEVIN KIRBY DIRECTOR OF CLINICAL DOSIMETRY 214522 0 0 0 0 0 6757 0 0 0 221279 0 0 0 TREVOR FLEMING DIRECTOR OF TECHNICAL SERVICES 203813 0 0 0 0 0 6337 0 0 0 210150 0 0 0 BRADLEE ROBBERT DIRECTOR OF OPERATIONS/SECRETARY (NON-VOTING) 158705 0 0 0 0 0 5047 0 0 0 163752 0 0 0 EMMA V VIVIERS TREATMENT PLANNING PHYSICIST 184407 0 0 0 0 0 5760 0 0 0 190167 0 0 0 WILLIAM J GLIDDEN LEAD CERTIFIED MEDICAL DOSIMETRIST 163208 0 0 0 0 0 4991 0 0 0 168199 0 0 0 NATALIYA GETMAN LEAD CERTIFIED MEDICAL DOSIMETRIST 157048 0 0 0 0 0 4869 0 0 0 161917 0 0 0 ST JOHN ERNEST TECHNICAL SERVICES MANAGER 147012 0 0 0 0 0 4543 0 0 0 151555 0 0 0 Schedule J, Part I, Line 3 Arrangement used to establish the top management official's compensation THE FILING ORGANIZATION'S EXECUTIVE DIRECTOR, KRISTIN HEATH, AND THE MEDICAL DIRECTOR, DR. NANCY MENDENHALL, WERE COMPENSATED BY THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE, AN UNRELATED ENTITY, FOR SERVICES PROVIDED TO THE FILING ORGANIZATION. THE EXECUTIVE DIRECTOR'S COMPENSATION WAS DETERMINED ACCORDING TO THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE'S POLICIES AND PROCEDURES. A JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 2012-08-01 25580000 SEE SUPPLEMENTAL INFORMATION - PART V true false false B JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 46936FAN8 2017-08-18 27250000 SEE SUPPLEMENTAL INFORMATION - PART V false false false C JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 46936FAN8 2017-08-18 27250000 SEE SUPPLEMENTAL INFORMATION - PART V false false false A 17749000 0 25580000 16874 0 0 0 0 0 0 25563126 0 2012 true false true true B 6706520 0 27240000 1800408 0 0 283371 0 0 6039492 19116729 0 2017 true false true true C 12575000 0 27225000 0 0 0 283371 0 0 7824900 19116729 0 2017 true false true true A false false false false false false 0 0 0.0 false false 0 false false B false false false false false false 0 0 0.0 false false 0 false false C false false false false false false 0 0 0.0 false false 0 false false A false false false true true true JP MORGAN CHASE BANK 20.0 false false false 0 false false true B false true false true true true TRUIST BANK 10.0 false false false 0 false false true C false true false true true true TRUIST BANK 10.0 false false false 0 false false true A true B false C false Schedule K, Part I, Column (f) LINES A & B THE SERIES 2007B BONDS AND SERIES 2017 BONDS WERE ISSUED PURSUANT TO THE INDENTURE, WHICH PROVIDES, AMONG OTHER THINGS, THAT THE INSTITUTE MAINTAIN CERTAIN MINIMUM FINANCIAL RATIOS. THE SERIES 2007B BONDS AND SERIES 2017 BONDS ARE COLLATERALIZED BY EQUIPMENT, MACHINERY, AND OTHER PERSONAL PROPERTY INCLUDING THE INSTITUTE'S GROSS REVENUES, AS DEFINED IN THE INDENTURE. ON AUGUST 1, 2012, AS PART OF A MODIFICATION OF THE SERIES 2007B BONDS, THE INSTITUTE REPAID $12,110,000 OF THE SERIES 2007B BONDS TO REDUCE THE REMAINING UNPAID PRINCIPAL BALANCE TO $32,580,000. THE SERIES 2007B BONDS WERE THEN REPLACED WITH (A) $25,580,000 OF SERIES 2007B-1 BONDS AND (B) $7,000,000 OF SERIES 2007B-2 BONDS. Schedule K, Part I, Column (f) LINES C & D ON AUGUST 18, 2017, THE INSTITUTE ISSUED SERIES 2017A BONDS AND SERIES 2017B BONDS PURSUANT TO AN INDENTURE (COLLECTIVELY, THE "SERIES 2017 BONDS") AS PART OF A REFINANCING OF THE 2007A BONDS. THE PROCEEDS OF THE SERIES 2017 BONDS, ALONG WITH THE REMAINING AVAILABLE BALANCE OF THE SERIES 2007A BOND FUND AND DEBT SERVICE RESERVE FUND WERE USED TO (A) REFUND THE REMAINING AMOUNTS DUE ON AND EXTINGUISH THE SERIES 2007A BONDS ON SEPTEMBER 1, 2017, (B) PAY THE COSTS OF ISSUANCE, AND (C) PROVIDE FUNDING FOR THE INSTITUTE'S PLANNED EXPANSION. Schedule K, Part IV, Line 2c COLUMN A Issuer name: JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION The calculation for computing no rebate due was performed on 06/30/2025 Schedule K, Part IV, Line 2c COLUMN B Issuer name: JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION The calculation for computing no rebate due was performed on 08/18/2025 Schedule K, Part IV, Line 2c COLUMN C Issuer name: JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION The calculation for computing no rebate due was performed on 08/18/2025 Form 990, Part VI, Line 7a Members or stockholders electing members of governing body The Dean of the University of Florida College of Medicine, the Chair of the University of Florida Department of Radiation Oncology, and the CEO of the Shands Jacksonville Medical Center each have the power to elect or appoint an individual to the governing body. The designee(s) may be changed at any time and from time to time upon thirty days' written notice to the Board. Form 990, Part VI, Line 11b Review of form 990 by governing body FORM 990 WILL FIRST BE REVIEWED AND APPROVED BY THE CHIEF FINANCIAL OFFICER. SUBSEQUENT TO THE CFO'S APPROVAL, FORM 990 WILL BE PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL PRIOR TO FILING IT WITH THE IRS. Form 990, Part VI, Line 12c Conflict of interest policy THE ORGANIZATION'S GOVERNING BODY MONITORS AND ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY ANNUALLY. THE GOVERNING BODY REVIEWS ACTUAL CONFLICTS, IF ANY, THAT ARE IDENTIFIED BY THE ANNUAL DISCLOSURE PROCESS AND PROHIBITS OFFICERS AND DIRECTORS FROM VOTING ON MATTERS WHERE ACTUAL CONFLICTS OF INTEREST EXIST. Form 990, Part VI, Line 15a Process to establish compensation of top management official THE EXECUTIVE DIRECTOR AND MEDICAL DIRECTOR'S COMPENSATION IS CONTROLLED AND APPROVED BY THE UNIVERSITY OF FLORIDA. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC AND ARE AVAILABLE UPON REQUEST. Form 990, Part IX, Line 11g Other Fees CONTRACTED HEALTHCARE SERVICES - Total Expense: 9666018, Program Service Expense: 9232922, Management and General Expenses: 433096, Fundraising Expenses: ; BILLING AND COLLECTION SERVICES - Total Expense: 1376334, Program Service Expense: 1376334, Management and General Expenses: , Fundraising Expenses: ; OTHER PURCHASED SERVICES - Total Expense: 405323, Program Service Expense: 405323, Management and General Expenses: , Fundraising Expenses: ; CONSULTING SERVICES - Total Expense: 86022, Program Service Expense: , Management and General Expenses: 86022, Fundraising Expenses: ; UF FOUNDATION MANAGEMENT FEES - Total Expense: 83459, Program Service Expense: , Management and General Expenses: 83459, Fundraising Expenses: ; Form 990, Part XI, Line 9 Other changes in net assets or fund balances CHANGE IN FAIR VALUE OF INTEREST RATE SWAP - -325046; Total - -325046; GENERAL DISCLOSURE CHARITY CARE THE INSTITUTE PROVIDES CARE TO PATIENTS WHO MEET CERTAIN CRITERIA UNDER ITS CHARITY CARE POLICY WITHOUT CHARGE OR AT AMOUNTS LESS THAN ITS ESTABLISHED RATES. BECAUSE THE INSTITUTE DOES NOT PURSUE COLLECTION OF AMOUNTS DETERMINED TO QUALIFY AS CHARITY CARE, THEY ARE NOT REPORTED AS NET PATIENT SERVICE REVENUE. DURING THE YEARS ENDED JUNE 30, 2025 AND 2024, THE INSTITUTE RECOGNIZED AN EXPLICIT PRICE CONCESSION FROM CHARITY CARE OF APPROXIMATELY $39,000 AND $474,000, RESPECTIVELY. THE TOTAL DIRECT AND INDIRECT COSTS OF THESE SERVICES WERE APPROXIMATELY $229,000 AND $541,000 FOR THE YEARS ENDED JUNE 30, 2025 AND 2024, RESPECTIVELY.